Clostridium Difficile Infection — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for clostridium difficile infection. 18 active patents protecting 1 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

1
Approved drugs
18
Active US patents
63/100
Avg vulnerability
$410M
Annual revenue covered

Originators in Clostridium Difficile Infection

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cubist Pharms Llc 18 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating clostridium difficile infection. Each bar = one year. Y-axis scaled to peak year (10 patents).

10
27
6
28
2
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Dificid
FIDAXOMICIN
 Cubist Pharms Llc 18 63 $410M 2027-03-04

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7906489 Dificid method of use 85 2027-03-04
7906489 Dificid method of use 80 2027-03-04
8859510 Dificid method of use 80 2027-07-31
8859510 Dificid method of use 75 2027-07-31
7906489 Dificid other 75 2027-09-04
7906489 Dificid other 75 2027-09-04
8859510 Dificid other 75 2028-01-31
7378508 Dificid other 75 2028-01-31
7378508 Dificid other 75 2028-01-31
7863249 Dificid other 75 2028-01-31

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7378508 Dificid composition of matter 17 2027-07-31
7378508 Dificid composition of matter 22 2027-07-31
7863249 Dificid composition of matter 22 2027-07-31
9808530 Dificid formulation 42 2034-05-28
7863249 Dificid formulation 55 2027-07-31
9808530 Dificid other 62 2034-11-28
8859510 Dificid other 75 2028-01-31
7378508 Dificid other 75 2028-01-31
7378508 Dificid other 75 2028-01-31
7863249 Dificid other 75 2028-01-31

Related